Systematic review with meta‐analysis: Vonoprazan, a potent acid blocker, is superior to proton‐pump inhibitors for eradication of clarithromycin‐resistant strains of <i>Helicobacter pylori</i>
Systematic review with meta‐analysis: Vonoprazan, a potent acid blocker, is superior to proton‐pump inhibitors for eradication of clarithromycin‐resistant strains of <i>Helicobacter pylori</i> is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Systematic review with meta‐analysis: Vonoprazan, a potent acid blocker, is superior to proton‐pump inhibitors for eradication of clarithromycin‐resistant strains of <i>Helicobacter pylori</i> have?
Systematic review with meta‐analysis: Vonoprazan, a potent acid blocker, is superior to proton‐pump inhibitors for eradication of clarithromycin‐resistant strains of <i>Helicobacter pylori</i> has 127 citations in the OpenAlex counts ScholarIQ stores.
When was Systematic review with meta‐analysis: Vonoprazan, a potent acid blocker, is superior to proton‐pump inhibitors for eradication of clarithromycin‐resistant strains of <i>Helicobacter pylori</i> published?
Systematic review with meta‐analysis: Vonoprazan, a potent acid blocker, is superior to proton‐pump inhibitors for eradication of clarithromycin‐resistant strains of <i>Helicobacter pylori</i> has 2018 year in the ScholarIQ index.
What is the open-access status of Systematic review with meta‐analysis: Vonoprazan, a potent acid blocker, is superior to proton‐pump inhibitors for eradication of clarithromycin‐resistant strains of <i>Helicobacter pylori</i>?
Systematic review with meta‐analysis: Vonoprazan, a potent acid blocker, is superior to proton‐pump inhibitors for eradication of clarithromycin‐resistant strains of <i>Helicobacter pylori</i> has closed oa status in the ScholarIQ index.
What is the DOI of Systematic review with meta‐analysis: Vonoprazan, a potent acid blocker, is superior to proton‐pump inhibitors for eradication of clarithromycin‐resistant strains of <i>Helicobacter pylori</i>?
The DOI for Systematic review with meta‐analysis: Vonoprazan, a potent acid blocker, is superior to proton‐pump inhibitors for eradication of clarithromycin‐resistant strains of <i>Helicobacter pylori</i> is on the source record.
What is the PMID of Systematic review with meta‐analysis: Vonoprazan, a potent acid blocker, is superior to proton‐pump inhibitors for eradication of clarithromycin‐resistant strains of <i>Helicobacter pylori</i>?
The PMID for Systematic review with meta‐analysis: Vonoprazan, a potent acid blocker, is superior to proton‐pump inhibitors for eradication of clarithromycin‐resistant strains of <i>Helicobacter pylori</i> is on the source record.
What is the OpenAlex record for Systematic review with meta‐analysis: Vonoprazan, a potent acid blocker, is superior to proton‐pump inhibitors for eradication of clarithromycin‐resistant strains of <i>Helicobacter pylori</i>?
The OpenAlex for Systematic review with meta‐analysis: Vonoprazan, a potent acid blocker, is superior to proton‐pump inhibitors for eradication of clarithromycin‐resistant strains of <i>Helicobacter pylori</i> is on the source record.